Jianping Chang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Systemic immune-inflammation index: a key biomarker guiding personalized adjuvant chemotherapy in intrahepatic cholangiocarcinoma.
Journal: Frontiers in oncology
Published: September 09, 2025
Prognostic Factors and Treatment Outcomes in Gallbladder Cancer Patients Undergoing Curative Surgery: A Multicenter Retrospective Cohort Study.
Journal: Current oncology (Toronto, Ont.)
Published: April 26, 2025
Gamma-Glutamyl Transferase Plus Carcinoembryonic Antigen Ratio Index: A Promising Biomarker Associated with Treatment Response to Neoadjuvant Chemotherapy for Patients with Colorectal Cancer Liver Metastases.
Journal: Current oncology (Toronto, Ont.)
Published: December 28, 2024
DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
Journal: Scientific reports
Published: January 16, 2024
Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation.
Journal: Journal of hepatocellular carcinoma
Published: November 29, 2023
Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
Journal: Journal of gastroenterology and hepatology
Published: September 03, 2023
MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1.
Journal: Cancer cell international
Published: May 05, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026